These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

911 related items for PubMed ID: 6368585

  • 21. Alterations in glucose metabolism in the elderly patient with diabetes.
    Meneilly GS, Dawson K, Tessier D.
    Diabetes Care; 1993 Sep; 16(9):1241-8. PubMed ID: 8404427
    [Abstract] [Full Text] [Related]

  • 22. Differential effects of insulin on splanchnic and peripheral glucose disposal after an intravenous glucose load in man.
    Saccà L, Cicala M, Trimarco B, Ungaro B, Vigorito C.
    J Clin Invest; 1982 Jul; 70(1):117-26. PubMed ID: 6123524
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. In vitro reversal of hyperglycemia normalizes insulin action in fat cells from type 2 diabetes patients: is cellular insulin resistance caused by glucotoxicity in vivo?
    Burén J, Lindmark S, Renström F, Eriksson JW.
    Metabolism; 2003 Feb; 52(2):239-45. PubMed ID: 12601640
    [Abstract] [Full Text] [Related]

  • 25. Fasting hyperglycemia normalizes oxidative and nonoxidative pathways of insulin-stimulated glucose metabolism in noninsulin-dependent diabetes mellitus.
    Mandarino LJ, Consoli A, Kelley DE, Reilly JJ, Nurjhan N.
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1544-51. PubMed ID: 2121778
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes.
    Meneilly GS, Elliott T.
    Diabetes Care; 1999 Jan; 22(1):112-8. PubMed ID: 10333911
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus.
    Gumbiner B, Polonsky KS, Beltz WF, Griver K, Wallace P, Brechtel G, Henry RR.
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1594-602. PubMed ID: 2189885
    [Abstract] [Full Text] [Related]

  • 32. Impact of obesity on insulin action in NIDDM.
    Campbell PJ, Carlson MG.
    Diabetes; 1993 Mar; 42(3):405-10. PubMed ID: 8432411
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Site of insulin resistance in type 1 diabetes: insulin-mediated glucose disposal in vivo in relation to insulin binding and action in adipocytes in vitro.
    Yki-Järvinen H, Taskinen MR, Kiviluoto T, Hilden H, Helve E, Koivisto VA, Nikkilä EA.
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1183-92. PubMed ID: 6490795
    [Abstract] [Full Text] [Related]

  • 35. Insulin action during pregnancy. Studies with the euglycemic clamp technique.
    Ryan EA, O'Sullivan MJ, Skyler JS.
    Diabetes; 1985 Apr; 34(4):380-9. PubMed ID: 3882502
    [Abstract] [Full Text] [Related]

  • 36. How insulin resistant are patients with noninsulin-dependent diabetes mellitus?
    Reaven GM, Chen YD, Donner CC, Fraze E, Hollenbeck CB.
    J Clin Endocrinol Metab; 1985 Jul; 61(1):32-6. PubMed ID: 3889039
    [Abstract] [Full Text] [Related]

  • 37. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin.
    Rebrin K, Steil GM, Getty L, Bergman RN.
    Diabetes; 1995 Sep; 44(9):1038-45. PubMed ID: 7657026
    [Abstract] [Full Text] [Related]

  • 38. Insulin secretion and insulin sensitivity defects are a common feature of mild, clinically homogeneous, recently diagnosed type II (non-insulin-dependent) diabetics.
    Pisu E, Lombardi A, De Benedictis D, Bozzo C, Chiara E, Baggiore C, Bruno A, Cravero L, Pagano G, Lenti G.
    Acta Diabetol Lat; 1986 Sep; 23(3):215-25. PubMed ID: 3538736
    [Abstract] [Full Text] [Related]

  • 39. Glucose effectiveness assessed under dynamic and steady state conditions. Comparability of uptake versus production components.
    Ader M, Ni TC, Bergman RN.
    J Clin Invest; 1997 Mar 15; 99(6):1187-99. PubMed ID: 9077526
    [Abstract] [Full Text] [Related]

  • 40. Effects of fasting on plasma glucose and prolonged tracer measurement of hepatic glucose output in NIDDM.
    Glauber H, Wallace P, Brechtel G.
    Diabetes; 1987 Oct 15; 36(10):1187-94. PubMed ID: 3308588
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 46.